Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Crompton Greaves Shares Rise on FY29-31 Outlook
• Escorts Kubota to Invest Rs 2,000 Crore in New UP Plant
• Brigade Enterprises Shares Jump 6% on HealthEdge Lease Deal
• Dhoot Transmission Hits 52-Week High, Stock Up 70% From IPO
• Premier Energies Order Book Swells to Rs 15,000 Cr

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.